The announcement details the resolutions passed during the second meeting of the seventh board of directors of Hunan Hansen Pharmaceutical Co., Ltd. on June 1, 2026. The board approved a proposal regarding the reduction of registered capital of an affiliated company and related transactions. The proposal received 6 votes in favor, with no abstentions or objections.
Summary generated by AI · Always verify with source document
Hunan Hansen Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.